US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems
01 juil. 2024 04h30 HE
|
Nexstim Oyj
Press release, Helsinki, 1 July 2024 at 11:30 AM (EEST) US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that it has received...
STALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in Biomedicines
27 juin 2024 07h10 HE
|
STALICLA
Press Release STALICLA’s precision psychiatry study highlights strong EEG-based target engagement of STP1 treatment in defined subgroup of patients with autism and numerical improvement in core...
Global Mental Health Screening Market Size To Worth USD 2.62 Billion By 2033 l CAGR of 11.78%
18 juin 2024 16h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , June 18, 2024 (GLOBE NEWSWIRE) -- The Global Mental Health Screening Market Size is to Grow from USD 0.86 Billion in 2023 to USD 2.62 Billion by 2033, at a Compound Annual...
Neurocognitively-Defined Subtypes in Bipolar Disorder: A Path to More Personalized Treatments - A Free Webinar from the Brain & Behavior Research Foundation
03 juin 2024 13h19 HE
|
Brain & Behavior Research Foundation
New York, June 03, 2024 (GLOBE NEWSWIRE) -- NEW YORK -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Neurocognitively-Defined Subtypes in Bipolar Disorder: A Path...
Optimizing Deep Brain Stimulation for Obsessive-Compulsive Disorder - A Free Webinar from the Brain & Behavior Research Foundation
07 mai 2024 11h13 HE
|
Brain & Behavior Research Foundation
New York, May 07, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Optimizing Deep Brain Stimulation for Obsessive-Compulsive Disorder” on...
Dr. Richard Goldberg Joins Real Brands' Board of Directors, Enters Consulting Agreement
07 mai 2024 08h30 HE
|
Real Brands Inc.
North Providence, RI, May 07, 2024 (GLOBE NEWSWIRE) -- Real Brands Inc. (OTCPK: RLBD) announced today that it has added Richard J. Goldberg, MD, MS, to its Board of Directors, and The Company has...
PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy
03 mai 2024 11h00 HE
|
PharmAla Biotech
PharmAla launches new educational resource for prescribers of MDMA through the Special Access Program
Global Psychiatry Collaboration and Licensing Deals Directory, 2019-2024: Deal Trends, Leading Deals by Value, Most Active Dealmakers, Financials Terms, and More
26 avr. 2024 10h16 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
PharmAla Closes Private Placement and Concurrent Debt Settlement
19 avr. 2024 08h35 HE
|
PharmAla Biotech
PharmAla completes private placement and concurrent debt settlement with Advisor.
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
15 avr. 2024 07h00 HE
|
Axsome Therapeutics, Inc.
AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting...